Carbidopa, Levodopa And Entacapone Tablet, Film Coated
Product Images NDC 62332-796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 62332-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbilevoent-12-5-50-200mg.jpg (Carbilevoent 12 5 50 200mg)

Carbilevoent-12-5-50-200mg.jpg (Carbilevoent 12 5 50 200mg)
This text contains information about Carbidopa, Levodopa, and Entacapone tablets. Each film-coated tablet contains Carbidopa USP 125mg, Levodopa USP 200mg, and Entacapone USP 200mg. The tablets are to be stored at 25°C (77°F) with excursions permitted to 15°-30°C (56-86°F). It is important to dispense the tablets in a tight container and keep them out of reach of children to prevent overdose. The package is child-resistant. The tablets should not be combined to achieve a higher strength tablet to avoid the risk of Entacapone overdose. The tablets are manufactured by Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA.*
FDA Label Image

Carbilevoent-18-75-75-200mg.jpg (Carbilevoent 18 75 75 200mg)

Carbilevoent-18-75-75-200mg.jpg (Carbilevoent 18 75 75 200mg)
The text provides information on a medication called Carbidopa, Levodopa, and Entacapone Tablets. It includes details about the dosage, storage conditions, and the ingredients in each tablet. The medication is manufactured by Alembic Pharmaceuticals and is child-resistant to prevent accidental overdose. It is advisable not to combine tablets to achieve a higher strength due to the risk of entacapone overdose. Care should be taken to keep the tablets out of reach of children.*
FDA Label Image

Carbilevoent-25-100-200mg.jpg (Carbilevoent 25 100 200mg)

FDA Label Image

Carbilevoent-31-25-125-200mg.jpg (Carbilevoent 31 25 125 200mg)

Carbilevoent-31-25-125-200mg.jpg (Carbilevoent 31 25 125 200mg)
Dosage information for a medication containing Carbidopa, Levodopa, and Entacapone is provided in the text. It mentions to swallow the tablet whole and not crush it. The package inset with NDC number 62332-798-31 should be referred for detailed instructions. The tablets should be stored at a temperature between 15-30°C. Each film-coated tablet contains specified amounts of Carbidopa, Levodopa, and Entacapone. The medication should be kept in a tightly closed container and out of reach of children. The text also includes a contact address in Bedminster, NJ 07921, USA for further information.*
FDA Label Image

Carbilevoent-37-5-150-200.jpg (Carbilevoent 37 5 150 200)

Carbilevoent-37-5-150-200.jpg (Carbilevoent 37 5 150 200)
This text provides information about a medication labeled as Sielow. The dosage instructions are to refer to the package insert with a specific NDC number. The medication contains Carbidopa, Levodopa, and Entacapone Tablets. It advises to store the tablets in a controlled room between 15-30°C. Each film-coated tablet contains specific amounts of Carbidopa, Levodopa, and Entacapone. There are warnings not to combine tablets to achieve a higher strength due to risks. The manufacturing company mentioned is Alembic Pharmaceuticals. The text also indicates to keep the medication out of children's reach.*
FDA Label Image

Carbilevoent-50-200-200mg.jpg (Carbilevoent 50 200 200mg)

Carbilevoent-50-200-200mg.jpg (Carbilevoent 50 200 200mg)
Dosage information and instructions for Carbidopa, Levodopa, and Entacapone Tablets are detailed here. The tablets should be swallowed whole and not crushed, split, or chewed. Storage conditions require keeping the medication at 25°C, with excursions permitted between 15-30°C. Dispense in a tight container and keep all drugs out of reach of children. The package is child-resistant and manufactured by Alembic Pharmaceuticals, Inc. Each film-coated tablet contains Carbidopa 50mg, Levodopa 200mg, and Entacapone 200mg. It is important not to combine tablets to achieve a higher strength due to the risk of Entacapone overdose. The packaging contains 100 tablets and includes the necessary pharmaceutical information, such as the National Drug Code (NDC) and manufacturer details.*
FDA Label Image

Carbilevoenta-carbidopa.jpg (Carbilevoenta Carbidopa)

FDA Label Image

Carbilevoenta-entacapone.jpg (Carbilevoenta Entacapone)

FDA Label Image

Carbilevoenta-levodopa.jpg (Carbilevoenta Levodopa)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.